Atilla, P. A. Et Al. 2018. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience. Hematology/ Oncology and Stem Cell Therapy , vol.11, no.1 , 13-17.

Atilla, P. A., Atilla, E., Bozdag, S. C., YÜKSEL, M., TOPRAK, S. K., TOPÇUOĞLU, P., ... DEMİRER, T.(2018). Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience. Hematology/ Oncology and Stem Cell Therapy , vol.11, no.1, 13-17.

Atilla, Pinar Et Al. "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience," Hematology/ Oncology and Stem Cell Therapy , vol.11, no.1, 13-17, 2018

Atilla, Pinar A. Et Al. "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience." Hematology/ Oncology and Stem Cell Therapy , vol.11, no.1, pp.13-17, 2018

Atilla, P. A. Et Al. (2018) . "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience." Hematology/ Oncology and Stem Cell Therapy , vol.11, no.1, pp.13-17.

@article{article, author={Pinar Ataca Atilla Et Al. }, title={Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience}, journal={Hematology/ Oncology and Stem Cell Therapy}, year=2018, pages={13-17} }